Scholarlink

<p>Natural killer (NK) cells are promising effectors for cancer immunotherapy, but their efficacy is limited by immunosuppressive tumor microenvironments. To uncover strategies for enhancing NK cell function, we establish a CRISPR loss-of-function screening platform for primary human NK cells by combining BaEVRless-pseudotyped lentiviral transduction of sgRNA libraries with Cas9 protein electroporation. This platform enables genome-scale interrogation of gene function in non-transformed NK cells. Kinome-focused and genome-wide screens identify key regulators of NK cell proliferation, cytotoxicity, and resistance to prostaglandin E<sub>2</sub> (PGE<sub>2</sub>)-mediated suppression. <i>STK17B</i> deletion enhances NK cell expansion, while loss of <i>CCDC53</i> boosts degranulation and cytotoxicity. We also uncover the CRL5 complex—including <i>RNF7</i>, <i>UBE2F</i>, and <i>CISH</i>—as critical inhibitors of IL-2 signaling and effector function under PGE<sub>2</sub> stress. These findings establish a scalable platform for CRISPR-based functional genomics in primary NK cells and reveal engineering targets to enhance NK cell persistence and efficacy in tumor microenvironments.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genome-wide CRISPR screens in primary human natural killer cells identify countermeasures against immunosuppressive environment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月15日

查看全文
  • Quoc Viet Nguyen,
  • Yi-Jun Lan,
  • Jason Cheng-Yu Chang,
  • Hsin-An Shih,
  • Jenifer Faustine,
  • Cheng-Chieh Chen,
  • Shu-Yu Ho,
  • Ching-Wen Cheng,
  • Tsu-Lan Chao,
  • Steven Lin

摘要

Natural killer (NK) cells are promising effectors for cancer immunotherapy, but their efficacy is limited by immunosuppressive tumor microenvironments. To uncover strategies for enhancing NK cell function, we establish a CRISPR loss-of-function screening platform for primary human NK cells by combining BaEVRless-pseudotyped lentiviral transduction of sgRNA libraries with Cas9 protein electroporation. This platform enables genome-scale interrogation of gene function in non-transformed NK cells. Kinome-focused and genome-wide screens identify key regulators of NK cell proliferation, cytotoxicity, and resistance to prostaglandin E2 (PGE2)-mediated suppression. STK17B deletion enhances NK cell expansion, while loss of CCDC53 boosts degranulation and cytotoxicity. We also uncover the CRL5 complex—including RNF7, UBE2F, and CISH—as critical inhibitors of IL-2 signaling and effector function under PGE2 stress. These findings establish a scalable platform for CRISPR-based functional genomics in primary NK cells and reveal engineering targets to enhance NK cell persistence and efficacy in tumor microenvironments.